
Economy · 26 days ago
India slashes cancer drug prices drastically
🇮🇳 INDIA — The National Pharmaceutical Pricing Authority in India has reduced the maximum retail prices of cancer medications by up to 93%, including a ₹72,921 drop for Thiotepa. This move aims to enhance affordability of critical treatments.
First reported by livemint.com · developing for 26 days · livemint.com
Why it matters
These reductions could save lives by making life-saving treatment more accessible.
Context
Drug pricing reforms are essential for expanding treatment access in India.